Galderma has announced the launch of Restylane Defyne and Restylane Refyne: the first Optimal Balance Technology (OBT)â€...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations gl...
South Korea-based startup Sky Labs Inc. has entered into an exclusive distribution agreement with Otsuka Pharmaceut...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.39 b...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the termination of the current rocatin...
SBC Medical Group Holdings Incorporated, a global provider of comprehensive consulting and management services to medica...
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (I...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
Japan-based H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio have announced the availability of the Lu...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
Japan-based companies Otsuka Pharmaceutical Co. and Towa Pharmaceutical Co. have entered into an agreement to establish ...
Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening ...
GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK...
Japanese pharmaceutical firm Takeda has announced a global collaboration and license agreement with US-based Halozyme Th...
Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the development...
Sweden-based medical technology and cybersecurity company Sectra, in collaboration with distribution partner Matsunami G...
Sanofi K.K. and Taiho Pharmaceutical have announced that the sales of the anticancer agent Jevtana® I.V. Infusion 60...
Japan's Shionogi & Co. will acquire a newly established company that Tanabe Pharma Corporation will create to hold t...
The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...
Fujifilm Corporation has announced the completion of one of Japan’s largest bio CDMO facilities (the new plan...
Soothe Healthcare, one of India’s leading personal hygiene and wellness companies, has signed a landmark Memorandu...
Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture ...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
Japan-based Chitose Laboratory Corp. and Fujifilm Biosciences Inc. have announced a new strategic alliance that leverage...
Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel...
Japan-based Olympus Corporation has announced an additional commitment to its corporate venture capital fund, ...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the Board of Directors’ decision...
Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US....
Japan-based Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY 70 million ...
A new combination therapy has shown promise in extending survival for patients with a specific type of lung cancer in As...
The Japanese Foundation for Cancer Research (JFCR), NEC Corporation, and Taiho Pharmaceutical Co. have signed a three-pa...
Japan's Fujitsu Limited has announced the development of a multi-AI agent collaboration technology that enable...
Australia's Telix Pharmaceuticals has announced the official opening of Telix Manufacturing Solutions (TMS) in Yoko...
Teijin Limited and BioVaram, the brand name of the UR Advanced Therapeutics Pvt Ltd. (URAT), si...
Japan-headquartered Nxera Pharma has announced a focused restructuring designed to concentrate investment and resources ...
As Japan transitions into a super-aged society, the demand for long-term care and assistive technologies is growing rapi...
US-based BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto ...
Japan's Kaneka Corporation has begun sales of its i-ED COIL™, a brain aneurysm embolisation coil, in Europe as of ...
NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medica...
Fujifilm Corporation has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national...
4D Molecular Therapeutics has announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialise ...
With the CDMO segment seeing rapid growth, how would you describe the changing profile of your clients, and how is Teiji...
German firm Boehringer Ingelheim has licensed a pre-clinical programme from Japan's Kyowa Kirin to develop a potential f...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.73 b...
MEDINET Japan and Stempeutics India (a group Company of Manipal Education & Medical Group) have signed an option lic...
Japan-based Renalys Pharma and Chugai Pharmaceutical have announced a definitive stock purchase agreement, under which C...
Japan-based medtech company Olympus Corporation has announced the launch of THUNDERBEAT™ II, the next generation h...
France-based Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based prod...
China's Innovent Biologics has announced a strategic global collaboration with Japanese pharmaceutical firm Takeda to ad...
Japan's Chugai Pharmaceutical and US-based Rani Therapeutics, LLC, a subsidiary of Rani Therapeutics Holdings, Inc., hav...
A.D.A.M. Innovations, Japan's leading private genetic testing company, and Swiss-based SOPHiA GENETICS, have announced a...
Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy® Subcutaneous...
The UK BioIndustry Association (BIA) and Japan Bioindustry Association (JBA) have signed a Memorandum of Understanding (...
Gunze Limited has announced that its wholly owned subsidiary, Gunze Medical Limited and US-based HistoSonics, Inc. have ...
Japan's startup Alpha Fusion Inc. has announced a joint initiative with the Kobe City Medical Center General Hospital (K...
Campus Create, one of Japan’s largest university-affiliated Technology Licensing Organisations (TLOs), has launche...
Germany-based Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) ...
Japanese pharmaceutical company Kubota Pharmaceutical Holdings Co., Ltd. will introduce Thailand to its ground...
Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer a...
Japanese pharmaceutical firm Daiichi Sankyo has established Daiichi Sankyo Research Institute in San Diego, US represent...
Zimmer Biomet Holdings, Inc., a global medical technology leader, has announced that the Pharmaceutical and Medical Devi...
Australia-based Cell Therapies and Japan's Teijin Limited have signed a Memorandum of Understanding ...
Japan-based medtech company Olympus Corporation has announced the commercial launch of its OLYSENSE™&nbs...
Lantheus Holdings, Inc. and GE HealthCare have announced an exclusive licensing agreement for GE HealthCare to develop, ...
Japan's Hitachi High-Tech Corporation, and Italy-based ELITechGroup S.p.A. have entered a Collaboration, Manufacturing a...
US-based Genomenon, a leading genomic intelligence company, has announced a strategic partnership with Taiwan headquarte...
Japan-based Shimadzu has released the FluxEdge GC System, equipped with FluxEdge, Shimadzu’s proprietary trac...
Japan's Sound Wave Innovation Co., Ltd. (SWI) and Sumitomo Heavy Industries, Ltd. (SHI) have announced the signing of a ...
Japan-based PHC Holdings Corporation and its subsidiary Ascensia Diabetes Care, a global diabetes care company, have ann...
Medipal Holdings Corporation and JCR Pharmaceuticals Co., have signed an exclusive global licensing deal ...
Rousselot, Darling Ingredients’ health brand, has been granted patents in Europe, Japan and China for Colartix, it...
Japan-based startup Celaid Therapeutics Inc. has executed a collaborative research agreement with AGC Inc. to advance&nb...
Nippon Kayaku, Formiica Pharmaceuticals and CBC Co. have agreed to jointly establish a joint venture (JV) for the purpos...
Japan's Meiji Seika Pharma has announced that its local subsidiary, Thai Meiji Pharmaceutical has received regulatory ap...
Terumo Corporation has entered into a definitive agreement with OrganOx Limited, a leading innovator in organ preservati...
US-based LinusBio, a leader in precision exposome medicine, has announced that ClearStrand-ASD™, its bio...
US-based Teleflex Incorporated, a leading global provider of medical technologies, has announced that Barrigel rectal sp...
Paris-based Nicox SA, an international ophthalmology company, has announced the signing of a major new agreement concern...
Japan-based Solasia Pharma has entered into a licensing agreement with Firebird Biologics (headquartered in Singapore) g...
South Korea based Biostar Stem Cell Technology Research Institute, led by Director Jeong Chan Ra, and jointly operated b...
Shimadzu will launch a particle analysis system in Japan and overseas, specialising in the analysis of micropl...
Astria Therapeutics, Inc. a US-based biopharmaceutical company, has exclusively licensed development and commercial...
Japan-headquartered Shimadzu Corporation and Kyoto University have signed a comprehensive collaborative agreement with t...
Viridian Therapeutics, Inc., a US-based biopharmaceutical company focused on discovering, developing, and commercialisin...
Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, has announced plans to construct a ...
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical...
Japan-based medtech company Olympus Corporation has signed a partnership with Revival Healthcare Capital to advance endo...
A nationwide public health initiative focused on gastric health and early detection of gastric cancer has been launched ...
Alloy Therapeutics Co. has announced the signing of a Memorandum of Understanding (MoU) with the Kansai Startup Academia...
The Global Antibiotic Research & Development Partnership (GARDP) and Institute of Science Tokyo, in Japan, have sign...
US-headquartered NKGen Biotech, Inc. a clinical-stage biotechnology company focused on the development and commerci...
Japan-headquartered Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately&nb...
(From Left to Right) Professor Kouichi Morita, Dean, Program Coordinator, Institute of Tropical Medicine, Nagasaki Un...
Japan's Fujitsu and Taiwan-based Acer Medical Inc., a provider of artificial intelligence (AI)-powered medical imaging a...
Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...
Omron Healthcare, a global leader in the field of clinically proven, innovative medical equipment for home health monito...
Leading GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therap...
Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR&rsq...
